ENTPD2 and neoplasm: CD8+ T cells are effector cells in tumor immunity, when MC38 cells were implanted into mice lacking CD8+ T cells using anti-mouse CD8a antibodies, the tumor-promoting effect of exosomal ENTPD2 was eliminated (P < 0.05, Fig. 4H-I).